UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 102

Sortiert nach

Lupus anticoagulant identifies two distinct groups of patients with different antibody patterns

Thrombosis research, 2018-12, Vol.172, p.172-178

2018

Volltextzugriff (PDF)

Thrombocytopenia in high‐risk patients with antiphospholipid syndrome

Journal of thrombosis and haemostasis, 2018-03, Vol.16 (3), p.529-532

2018

Volltextzugriff (PDF)

Usefulness of the Total Thrombus-Formation Analysis System (T-TAS) in the diagnosis and characterization of von Willebrand disease

Haemophilia : the official journal of the World Federation of Hemophilia, 2016-11, Vol.22 (6), p.949-956

2016

Volltextzugriff (PDF)

An in vitro model to mimic the thrombotic occlusion of small vessels in catastrophic antiphospholipid syndrome (CAPS)

Lupus, 2019-12, Vol.28 (14), p.1663-1668

2019

Volltextzugriff (PDF)

Identifying Carriers of Type 2N von Willebrand Disease: Procedures and Significance

Clinical and applied thrombosis/hemostasis, 2007-04, Vol.13 (2), p.194-200

2007

Volltextzugriff (PDF)

Abnormalities of von Willebrand factor are also part of the prothrombotic state of Cushingʼs syndrome

Blood coagulation & fibrinolysis, 1999-04, Vol.10 (3), p.145-152

1999

Volltextzugriff (PDF)

von Willebrand factor abnormalities in aortic valve stenosis: Pathophysiology and impact on bleeding

Thrombosis and haemostasis, 2011-07, Vol.106 (1), p.58

2011

Volltextzugriff (PDF)

Von Willebrand factor collagen binding activity in the diagnosis of von Willebrand disease: an alternative to ristocetin co‐factor activity?

British journal of haematology, 2001-03, Vol.112 (3), p.578-583

2001

Volltextzugriff (PDF)

Post-DDAVP thrombocytopenia in type 2B von Willebrand disease is not associated with platelet consumption: failure to demonstrate glycocalicin increase or platelet activation

Thrombosis and haemostasis, 1999-02, Vol.81 (2), p.224

1999

Volltextzugriff (PDF)

Reduced survival of type 2B von Willebrand factor, irrespective of large multimer representation or thrombocytopenia

Haematologica (Roma), 2010-08, Vol.95 (8), p.1366-1372

2010

Volltextzugriff (PDF)

Loss of cysteine 584 impairs the storage and release, but not the synthesis of von Willebrand factor

Thrombosis and haemostasis, 2014-12, Vol.112 (6), p.1159

2014

Volltextzugriff (PDF)

An apparently silent nucleotide substitution (c.7056C>T) in the von Willebrand factor gene is responsible for type 1 von Willebrand disease

Haematologica (Roma), 2011-06, Vol.96 (6), p.881-887

2011

Volltextzugriff (PDF)

EDTA dependent pseudothrombocytopenia caused by antibodies against the cytoadhesive receptor of platelet gpIIB-IIIA

Journal of clinical pathology, 1994-07, Vol.47 (7), p.625-630

1994

Volltextzugriff (PDF)

Lack of multimer organization of von Willebrand factor in an acquired von Willebrand syndrome

British journal of haematology, 2002-03, Vol.116 (4), p.899-904

2002

Volltextzugriff (PDF)

Reduced von Willebrand factor survival in type Vicenza von Willebrand disease

Blood, 2002-01, Vol.99 (1), p.180-184

2002

Volltextzugriff (PDF)

Which assay is the most suitable to investigate von Willebrand factor functional activity?

Thrombosis and haemostasis, 1999-06, Vol.81 (6), p.994

1999

Volltextzugriff (PDF)

C2362F mutation gives rise to an ADAMTS13-resistant von Willebrand factor

Thrombosis and haemostasis, 2013-06, Vol.109 (6), p.999

2013

Volltextzugriff (PDF)

A common ancestor more than 10,000 years old for patients with R854Q-related type 2N von Willebrand's disease in Italy

Haematologica (Roma), 2013-01, Vol.98 (1), p.147-152

2013

Volltextzugriff (PDF)

Diagnosis and Follow-up of Thrombotic Thrombocytopenic Purpura by Means of von Willebrand Factor Collagen Binding Assay

Clinical and applied thrombosis/hemostasis, 2006-07, Vol.12 (3), p.296-304

2006

Volltextzugriff (PDF)

Type 2N von Willebrand disease due to Arg91Gln substitution and a cytosine deletion in exon 18 of the von Willebrand factor gene

British journal of haematology, 1998-10, Vol.103 (1), p.39-41

1998

Volltextzugriff (PDF)

Two novel mutations (Pro864His, Val867Glu) causing type 2A von Willebrand disease and affecting a single restriction site in exon 28

British journal of haematology, 1998-12, Vol.103 (3), p.885-887

1998

Volltextzugriff (PDF)

Plasma and Platelet von Willebrand Factor Abnormalities in Patients With Uremia: Lack of Correlation With Uremic Bleeding

Clinical and applied thrombosis/hemostasis, 2001-04, Vol.7 (2), p.81-86

2001

Volltextzugriff (PDF)

Type IIB von Willebrand factor induces phospholipase A2 activation and cytosolic Ca2+ increase in platelets

Biochemical and biophysical research communications, 1995-09, Vol.214 (1), p.102-109

1995

Volltextzugriff (PDF)

On the release of von Willebrand factor from endothelial cells after venous occlusion

Thrombosis and haemostasis, 1998-06, Vol.79 (6), p.1216

1998

Volltextzugriff (PDF)

An Arg760Cys mutation in the consensus sequence of the von Willebrand factor propeptide cleavage site is responsible for a new von Willebrand disease variant

Blood, 2003-01, Vol.101 (1), p.151-156

2003

Volltextzugriff (PDF)

1 – 25 von 102

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(83)
Mit Volltextzugriff
(82)

Publikationsform

Artikel
(99)
Buchkapitel
(3)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(55)
Science & Technology
(47)
Life Sciences & Biomedicine
(45)
Female
(37)
Hematology
(35)
Biological And Medical Sciences
(34)
Medical Sciences
(34)
Male
(32)
Adult
(30)
Von Willebrand Factor - Metabolism
(24)
Hematologic And Hematopoietic Diseases
(23)
Platelet Diseases And Coagulopathies
(23)
Middle Aged
(19)
Von Willebrand Diseases - Blood
(17)
Von Willebrand Diseases - Genetics
(16)
Cardiovascular System & Cardiology
(15)
Peripheral Vascular Disease
(15)
Von Willebrand Factor
(15)
Von Willebrand Factor - Genetics
(15)
Von Willebrand Factor - Chemistry
(13)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Lupus anticoagulant identifies two distinct groups of patients with different antibody patterns

Thrombocytopenia in high‐risk patients with antiphospholipid syndrome

Usefulness of the Total Thrombus-Formation Analysis System (T-TAS) in the diagnosis and characterization of von Willebrand disease

An in vitro model to mimic the thrombotic occlusion of small vessels in catastrophic antiphospholipid syndrome (CAPS)

Identifying Carriers of Type 2N von Willebrand Disease: Procedures and Significance

Abnormalities of von Willebrand factor are also part of the prothrombotic state of Cushingʼs syndrome

von Willebrand factor abnormalities in aortic valve stenosis: Pathophysiology and impact on bleeding

Von Willebrand factor collagen binding activity in the diagnosis of von Willebrand disease: an alternative to ristocetin co‐factor activity?

Post-DDAVP thrombocytopenia in type 2B von Willebrand disease is not associated with platelet consumption: failure to demonstrate glycocalicin increase or platelet activation

Reduced survival of type 2B von Willebrand factor, irrespective of large multimer representation or thrombocytopenia

Loss of cysteine 584 impairs the storage and release, but not the synthesis of von Willebrand factor

An apparently silent nucleotide substitution (c.7056C>T) in the von Willebrand factor gene is responsible for type 1 von Willebrand disease

EDTA dependent pseudothrombocytopenia caused by antibodies against the cytoadhesive receptor of platelet gpIIB-IIIA

Lack of multimer organization of von Willebrand factor in an acquired von Willebrand syndrome

Reduced von Willebrand factor survival in type Vicenza von Willebrand disease

Which assay is the most suitable to investigate von Willebrand factor functional activity?

C2362F mutation gives rise to an ADAMTS13-resistant von Willebrand factor

A common ancestor more than 10,000 years old for patients with R854Q-related type 2N von Willebrand's disease in Italy

Diagnosis and Follow-up of Thrombotic Thrombocytopenic Purpura by Means of von Willebrand Factor Collagen Binding Assay

Type 2N von Willebrand disease due to Arg91Gln substitution and a cytosine deletion in exon 18 of the von Willebrand factor gene

Two novel mutations (Pro864His, Val867Glu) causing type 2A von Willebrand disease and affecting a single restriction site in exon 28

Plasma and Platelet von Willebrand Factor Abnormalities in Patients With Uremia: Lack of Correlation With Uremic Bleeding

Type IIB von Willebrand factor induces phospholipase A2 activation and cytosolic Ca2+ increase in platelets

On the release of von Willebrand factor from endothelial cells after venous occlusion

An Arg760Cys mutation in the consensus sequence of the von Willebrand factor propeptide cleavage site is responsible for a new von Willebrand disease variant

Suchergebnisse filtern